Black Rock Inc. Evolus, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Evolus, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,260,786 shares of EOLS stock, worth $34.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,260,786

Previous 3,339,377 2.35%

Holding current value

$34.1 Million

Previous $35.2 Million 29.83%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$9.99 - $14.91 $785,124 - $1.17 Million	-78,591 Reduced 2.35%	3,260,786 $45.7 Million
Q4 2023 Feb 13, 2024	BUY	$7.6 - $10.53 $2.78 Million - $3.85 Million	365,839 Added 12.3%	3,339,377 $35.2 Million
Q3 2023 Nov 13, 2023	SELL	$7.15 - $10.2 $156,213 - $222,849	-21,848 Reduced 0.73%	2,973,538 $27.2 Million
Q2 2023 Aug 11, 2023	BUY	$7.23 - $10.52 $4.01 Million - $5.83 Million	554,417 Added 22.71%	2,995,386 $21.8 Million
Q1 2023 May 12, 2023	SELL	$7.81 - $11.05 $222,327 - $314,560	-28,467 Reduced 1.15%	2,440,969 $20.7 Million

Q4 2022 Feb 13, 2023	BUY	$6.52 - $8.95 $460,103 - $631,583	70,568 Added 2.94%	2,469,436 $18.5 Million
Q3 2022 Nov 14, 2022	BUY	$7.76 - $13.72 $144,498 - $255,480	18,621 Added 0.78%	2,398,868 $19.3 Million
Q2 2022 Aug 12, 2022	BUY	$10.22 - $13.94 $1.82 Million - $2.49 Million	178,475 Added 8.11%	2,380,247 $27.6 Million
Q1 2022 May 12, 2022	SELL	$5.22 - $11.78 $131,277 - $296,255	-25,149 Reduced 1.13%	2,201,772 $24.7 Million
Q4 2021 Feb 10, 2022	BUY	$5.37 - $8.38 $292,831 - $456,969	54,531 Added 2.51%	2,226,921 $14.5 Million
Q3 2021 Nov 09, 2021	BUY	$7.36 - $13.67 $331,376 - $615,478	45,024 Added 2.12%	2,172,390 $16.6 Million
Q2 2021 Aug 11, 2021	BUY	$8.42 - $13.96 $17.9 Million - $29.7 Million	2,127,366 New	2,127,366 $26.9 Million

Others Institutions Holding EOLS

# of Institutions

173

Shares Held

47M

Call Options Held

720K

Put Options Held

532K

View Full List

About Evolus, Inc.

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $586M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

More about EOLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account